Right now with SGYP I am watching the last price 5.52 High 5.60 Low 5.51 Change -0.15 and percent change -2.65%
Do you have any opinions about SGYP stock? Share them with me. I would like to know.
SGYP Synergy Pharmaceuticals Inc
Nonprofit Models Shine Amid IRS Scrutiny Out in Oxnard, California, there's a brewing storm in the healthcare sector. No, it's not a billing error or yet another scandal. We're talking about a seismic shift that could poke holes in those tax-engineered Section 105(b) programs, all thanks to some hard-hitting IRS memoranda. The Nonprofit–TPA Model: A Safer Bet? Enter...
Continue Reading
Young Artists Called to Inspire a Cancer-Free World What's the first image that pops into your head when you think of a world free from cancer? That's the magic question on deck for this year's Youth Art Contest by Debbie's Dream Foundation. Imaginations are set to run wild as the competition opens its gates to artists under 18, calling for visions splashed across...
Continue Reading
Big Moves in the Financial Advisory World Let's dive right in. Here's a real shakeup in the advisory realm: 28 financial advisors and team members from Sierra Ridge Advisor Group are packing their bags for Gateway Financial Partners. We're talking about a significant shift involving $825 million in assets under advisement. Instead of sticking with Sierra Ridge as it...
Continue Reading
Revolutionizing Viticulture with Data In today's wild world, climate change isn't just shifting weather patterns—it's upending the age-old map of wine-making regions. We've got a new player on the field: the World Winery Map. It's digital, massive, and it’s shaking things up for winemakers and grape enthusiasts alike. This platform covers a staggering 4.3 million...
Continue Reading
Debt Reality: A National Concern with Global Implications When it comes to the U.S. federal debt situation, the latest report from the National Seniors Policy Center is lighting a fire like no other, warning us that we're not crying wolf here. We've got fiscal numbers that may not sit well at breakfast. With roughly 67 cents of every new buck Uncle Sam borrows going to...
Continue Reading
A Month to Celebrate Unseen Heroes Take a pause. We're talking about National Service Dog Month. What in the world could be more endearing than a pack of puppies, those hopeful bundles of joy, destined to grow up and play pivotal roles in people's lives? Canine Companions is rolling out the red carpet for these future heroes, with a nine-day Puppy Cam event from September...
Continue Reading
New Kid on the Block: Cheez Nugs Buckle up folks, Crimson Coward is at it again. They're rolling out something they claim will blow your taste buds straight out of the water: Cheez Nugs. Dropping nationwide on September 18, 2026, these aren't your run-of-the-mill cheese bites. We're talking 100% whole-milk mozzarella, a golden herb-seasoned crust, and a mouthful of creamy...
Continue Reading
Unlikely Spotlight on Menopause at Capitol Hill If you told me a couple of years back that menopause would become a front-page political issue, I would've laughed. Yet, here we are, with over 125 advocates from 29 states converging on Washington, D.C., demanding legislative action on menopause. Why Menopause Matters in Policy The fact that more than half the population is...
Continue Reading
End of an Era: Warren Buffett's Retirement Warren Buffett—there's a name that's echoed through the halls of investment for decades. Today, he's pulling down the curtain as Chairman of Berkshire Hathaway (NYSE: BRK). No fanfare, just a nod to the inevitable with his classic, humor-tinged confession: 'Father Time always wins.' Can’t argue with the man who’s seen the...
Continue Reading
Navigating the AI Terrain in Arbitration It's 2026 and artificial intelligence isn't just a buzzword anymore; it's reshaping every corner of how disputes get resolved. The American Arbitration Association (AAA) has jumped into the mix, launching an AI Ambassador program to tackle a wave of AI-induced challenges. These aren't just academic exercises—this is a hard-nosed...
Continue Reading
Cingulate's Recent Financing Move Cingulate Inc. (NASDAQ: CING), a prominent player in the biopharmaceutical arena, has recently announced a significant financing transaction. This initiative has successfully provided the company with net proceeds totaling $5 million, a crucial boost intended to enhance its operational capabilities. The financing arrangement was carefully...
Continue Reading
NATSO and SIGMA Advocate for Continuation of Biodiesel Tax Credit NATSO, which represents truck stops and travel centers, alongside SIGMA, a leading fuel marketers association, is pushing Congress to seize the opportunity to extend the important biodiesel blenders' tax credit of $1 per gallon. As these organizations represent a significant portion of the retail fuel...
Continue Reading
Community Healthcare Trust's Latest Financial Performance Community Healthcare Trust Incorporated (NYSE: CHCT) recently released its financial results for the three months ended September 30, 2025. The company has shown remarkable growth, underscoring its strategic aim of supporting healthcare in the evolving landscape of real estate investment. With net income nearing...
Continue Reading
ALX Oncology Pioneers a New Era in Cancer Treatment ALX Oncology is stepping into the limelight with its new antibody-drug conjugate (ADC), ALX2004, which is specifically designed to target EGFR-expressing solid tumors. This unique formulation boasts an optimized therapeutic profile, minimizing toxicity while maximizing therapeutic potential. The company is paving the way...
Continue Reading
TFI International's Dividend Announcement Recently, TFI International Inc. (NYSE and TSX: TFII), a prominent player in the transportation and logistics sector, made a significant announcement that is likely to please its shareholders. The company has declared a quarterly dividend of US $0.45 per outstanding common share. This payment is set to be made on a specified date...
Continue Reading